Storage and handling
Other Information : store below 25C (77F), avoid direct sunlight
Other Information : store below 25C (77F), avoid direct sunlight
Active Ingredient
Allantoin 2.00 %
Lidocaine 4.00 %
Pterolatum 30.00 %
Purpose
Allantoin 2.00 % ........ Skin Protectant
Lidocaine 4.00 % ........ Topical Anesthetic
Petrolatum 30.00 %..... Skin Protectant
Uses
- Scar Management - Temporarily protects minor cuts, scrapes and burns
-Temporary relief of pain associated with minor cuts, scrapes and minor skin irritations
Warnings
For external use only
Do not use
-on deep or puncture wounds, animal bites, serious burns
-in large quantities, particularly over raw surfaces or blistered areas
When using this product
-avoid contact with eyes
Stop use and ask a doctor if
-condition worsens symptoms last more than 7 days or clear up and occur again within a few days
Keep out of reach of children. If pregnant or breastfeeding, contact physician prior to use
Directions:
How to apply - clean and dry affected area -remove mesh from backing and apply to affected area
-use only one mesh at a time, and maximum of four mesh/day -leave mesh on affected area for up to
8 hours -do not use mesh for longer than 5 consecutive days -children under 12 should consult
physician prior to use
Other Information: store below 25C (77F), avoid direct sunlight
Questions or comments? call weekdays from 9 AM to 5 PM CST 800-914-7435
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69512-020-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4591-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69512-020-01 | Premium Scar Patch | 15 in 1 BOX | PATCH | 15 | 3 | |
| 69512-020-01 | Premium Scar Patch | 15 g in 1 PATCH | PATCH | 15 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69512-020-01 | EA - Each | 69512-020 | 80a80920-5168-4259-ac9c-98cd63176c6d | 1 | 2015-10-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALLANTOIN | ACTIVE INGREDIENT | 344S277G0Z | 3 | |
| LIDOCAINE | ACTIVE INGREDIENT | 98PI200987 | 3 | |
| PETROLATUM | ACTIVE INGREDIENT | 4T6H12BN9U | 3 | |
| ALLANTOIN | ACTIVE MOIETY | 344S277G0Z | 3 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | 3 | |
| PETROLATUM | ACTIVE MOIETY | 4T6H12BN9U | 3 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 3 | |
| ONION | INACTIVE INGREDIENT | 492225Q21H | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69512-020 | 69512-020-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALLANTOIN | 344S277G0Z | ACTIB |
| LIDOCAINE | 98PI200987 | ACTIB |
| PETROLATUM | 4T6H12BN9U | ACTIB |
| .ALPHA.-TOCOPHEROL | H4N855PNZ1 | IACT |
| ONION | 492225Q21H | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, FILM COATED / ORAL | 246 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | CAPSULE / ORAL | 16 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SOLUTION / ORAL | 1.05 mg/1ml | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET / ORAL | 2 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | FILM, SOLUBLE / BUCCAL | 0.07 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, CHEWABLE / ORAL | 0.1 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.64 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8ebdaa79-4eb9-4e26-8545-941e8032d713 | c3f3e86f-0def-4fd9-96dd-22931d78081c | 2015-04-13 | Warnings | 8ebdaa79-4eb9-4e26-8545-941e8032d713 c3f3e86f-0def-4fd9-96dd-22931d78081c |
Adverse event summaries are temporarily unavailable. Other product information remains available.